- Report
- January 2024
- 120 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- June 2023
- 150 Pages
North America
From €4534EUR$4,950USD£3,854GBP
- Report
- February 2024
- 150 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- May 2024
- 136 Pages
Global
From €5953EUR$6,499USD£5,060GBP
- Report
- May 2024
- 129 Pages
Global
From €5953EUR$6,499USD£5,060GBP
- Report
- August 2022
- 115 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- October 2023
- 133 Pages
Global
From €3893EUR$4,250USD£3,309GBP
- Report
- November 2023
- 115 Pages
United States
From €3435EUR$3,750USD£2,920GBP
- Report
- June 2023
- 115 Pages
United States
From €3435EUR$3,750USD£2,920GBP
- Report
- February 2023
- 134 Pages
Global
From €6870EUR$7,500USD£5,839GBP
- Report
- February 2023
- 67 Pages
Global
From €3618EUR$3,950USD£3,075GBP
- Report
- January 2022
- 60 Pages
Global
From €3618EUR$3,950USD£3,075GBP
- Report
- January 2022
- 60 Pages
Global
From €3618EUR$3,950USD£3,075GBP
- Report
- April 2023
- 160 Pages
Global
From €4534EUR$4,949USD£3,853GBP
- Report
- March 2024
- 200 Pages
Global
From €3802EUR$4,150USD£3,231GBP
- Report
- August 2022
- 114 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- May 2024
- 200 Pages
Global
From €3802EUR$4,150USD£3,231GBP
- Report
- April 2022
- 58 Pages
Global
From €3202EUR$3,495USD£2,721GBP
- Report
- July 2019
- 31 Pages
Global
From €3660EUR$3,995USD£3,110GBP
- Report
- March 2024
- 127 Pages
Europe
From €1374EUR$1,500USD£1,168GBP

The Alopecia Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases. Alopecia is an autoimmune disorder that causes hair loss, and drugs used to treat it are designed to reduce inflammation and suppress the immune system. These drugs are typically administered orally or topically, and may include corticosteroids, immunosuppressants, and biologics.
The Alopecia Drug market is highly competitive, with many companies developing treatments for the disorder. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. Other companies, such as Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories, are also active in the market. Show Less Read more